Bowel function and bother after treatment for early stage prostate cancer: A longitudinal quality of life analysis from CaPSURE

Journal of Urology

Volumn 172, Issue 2, 2004, Pages 515-519

  Litwin, Mark S ^a,c   Sadetsky, Natalia ^b   Pasta, David J ^b   Lubeck, Deborah P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brachytherapy; Prostatectomy; Prostatic neoplasms; Quality of life; Radiation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COMORBIDITY; HEALTH SURVEY; HUMAN; INTESTINE FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; PROSTATECTOMY; QUALITY OF LIFE; SEXUAL FUNCTION; TREATMENT OUTCOME;

EID: 3142653152     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000129236.56712.e7     Document Type: Article

References (20)

1. Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Haggman, M. et al: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med, 347: 781, 2002
2. Clark, J. A., Bokhour, B. G., Inui, T. S., Silliman, R. A. and Talcott, J. A.: Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care, 41: 923, 2003
3. Potosky, A. L., Harlan, L. C., Stanford, J. L., Gilliland, F. D., Hamilton, A. S., Albertsen, P. C. et al: Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst, 91: 1719, 1999
4. Talcott, J. A., Rieker, P., Clark, J. A., Propert, K. J., Weeks, J. C., Beard, C. J. et al: Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol, 16: 275, 1998
5. Singer, P. A., Tasch, E. S., Stocking, C., Rubin, S., Siegler, M. and Weichselbaum, R.: Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol, 9: 328, 1991
6. Saigal, C. S., Gornbein, J., Nease, R. and Litwin, M. S.: Predictors of utilities for health states in early stage prostate cancer. J Urol, 166: 942, 2001
7. Lubeck, D. P., Litwin, M. S., Henning, J. M., Stier, D. M., Mazonson, P., Fisk, R. et al: The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology, 48: 773, 1996
8. Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B. and Brook, R. H.: The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care, 36: 1002, 1998
9. Ware, J. E., Jr. and Sherbourne, C. D.: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care, 30: 473, 1992
10. Juniper, E. F., Guyatt, G. H., Willan, A. and Griffith, L. E.: Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol, 47: 81, 1994
11. Greenfield, S., Apolone, G., McNeil, B. J. and Cleary, P. D.: The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care, 31: 141, 1993
12. Lubeck, D. P., Litwin, M. S., Henning, J. M. and Carroll, P. R.: Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res, 6: 385, 1997
13. Davis, J. W., Kuban, D. A., Lynch, D. F. and Schellhammer, P. F.: Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol, 166: 947, 2001
14. Skwarchuk, M. W., Jackson, A., Zelefsky, M. J., Venkatraman, E. S., Cowen, D. M., Levegrun, S. et al: Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys, 47: 103, 2000
15. Bacon, C. G., Giovannucci, E., Testa, M. and Kawachi, I.: The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol, 166: 1804, 2001
16. Merrick, G. S., Butler, W. M., Dorsey, A. T., Galbreath, R. W., Blatt, H. and Lief, J. H.: Rectal function following prostate brachytherapy. Int J Radiat Oncol Biol Phys, 48: 667, 2000
17. Nag, S., Ellis, R. J., Merrick, G. S., Bahnson, R., Wallner, K., Stock, R. et al: American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. Int J Radiat Oncol Biol Phys, 54: 462, 2002
18. Merrick, C. S., Wallner, K. E. and Butler, W. M.: Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol, 169: 1643, 2003
19. Blatt, H. J., Abel, L. J., Stipetich, R. L., Galbreath, R. W., Lief, J. H., Butler, W. M. et al: Utilization of a self-administered questionnaire to assess rectal function following prostate brachytherapy. Urol Nurs, 21: 356, 2001
20. Fowler, F. J., Jr., Barry, M. J., Lu-Yao, G., Wasson, J. H. and Bin, L.: Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol, 14: 2258, 1996